• Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

    المصدر: Buzz FX / 04 يناير 2025 03:16:14   America/New_York


    Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat January 4, 2025 Share Link copied to clipboard. Shares of Viridian Therapeutics, Inc.
    Read more...
شارك على،